RxDoctor Payments Data

Regina Mangano

Nurse Practitioner · Mullica Hill, NJNPI 1760197230

Payments from drug & device makers

$1,064in general payments, 2019–2025

Across 56 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$163
  • Boehringer Ingelheim$134
  • Amgen$133
  • Novo Nordisk$102
  • Novartis$90
  • Bayer$90
  • plus $351 from 10 others

What the payments were for

  • Food & beverage$1,064100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,064 in reported general payments places this provider in the 80th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Medicare billing

Part B allowed, 2024
$11,448
Medicare patients
87
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$86,882
XareltoRivaroxaban44$40,909
EntrestoSacubitril/Valsartan20$21,094
FarxigaDapagliflozin Propanediol16$13,096
Metoprolol Succinate163$3,101
Valsartan31$1,241
Atorvastatin Calcium91$860
Rosuvastatin Calcium48$823
Losartan Potassium46$506
Lisinopril81$483
Midodrine Hcl12$480
Ezetimibe14$428
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$423
ClopidogrelClopidogrel Bisulfate37$416
Amlodipine Besylate65$371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$86,88269 claims
Johnson & JohnsonXarelto$63$40,90944 claims
NovartisEntresto$90$21,09420 claims
AstraZenecaFarxiga$163$13,09616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Mullica Hill

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →